Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
China SXT Pharmaceuticals Inc
SXTC | US
2.04
USD0.04
2.00%
SXTC | US
About China SXT Pharmaceuticals Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
05/03/2026
Close
2.04
Open
2.05
High
2.11
Low
2.02
China SXT Pharmaceuticals Inc. a pharmaceutical company engages in the research development manufacture marketing and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced fine and regular TCMP products such as ChenXiang SanQiFen HongQi SuMu JiangXiang CuYanHuSuo XiaTianWu LuXueJing XueJie ChaoSuanZaoRen HongQuMi ChuanBeiMu HuangShuKuiHua WuWeiZi DingXiang RenShen QingGuo JueMingZi and ShaRen. It provides its products under the Suxuantang Hui Chun Tang and Tong Ren Tang brands. As of March 31 2022 it had an end-customer base of 68 pharmaceutical companies 14 chain pharmacies and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou China.
View LessSXTC | US
Risk
154.5
Sharpe
-0.40
Luna's Score
54/100
Recommendation
Hold
Luna says (SXTC | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
91.4%1 month
154.5%3 months
271.3%6 months
208.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.16
Debt to equity
0.19
Debt to assets
0.11
Ent. to EBITDA
-0.36
Ent. to rev.
0.41
PEG
-
Other Fundamentals
EBITDA
-1.89M
MarketCap
7.09M
MarketCap(USD)
7.09M
Div. yield
-
Op. margin
733.81
Erngs. growth
42.60
Rev. growth
29.50
Ret. on equity
-21.65
Short ratio
0.20
Short perc.
7.54
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.81
Range1M
4.52
Range3M
6.95
Volumes: Market Activity
Rel. volume
0.06
Price X volume
45.35K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.36 | 24.85 | Cheaper |
| Ent. to Revenue | 0.41 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.16 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 271.35 | 65.24 | Riskier |
| Debt to Equity | 0.19 | -1.88 | Expensive |
| Debt to Assets | 0.11 | 0.48 | Cheaper |
| Market Cap | 7.09M | 3.71B | Emerging |
